ARDELYX, INC. Cash and Cash Equivalents, Fair Value Disclosure
ARDELYX, INC. (ARDX) had Cash and Cash Equivalents, Fair Value Disclosure of $75.29 million as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2021-11-12
- 2021-09-30: Cash and Cash Equivalents, Fair Value Disclosure $75.29M.
- 2021-06-30: Cash and Cash Equivalents, Fair Value Disclosure $86.75M.
- 2021-03-31: Cash and Cash Equivalents, Fair Value Disclosure $84.07M.
- 2020-12-31: Cash and Cash Equivalents, Fair Value Disclosure $91.03M.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure |
|---|---|
| 2021-09-30 | $75.29M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $86.75M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $84.07M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $91.03M 10-Q · filed 2021-11-12 |
| 2020-09-30 | $91.01M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $100.49M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $105.89M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $181.13M 10-K · filed 2021-03-08 |
| 2019-09-30 | $92.67M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $89.63M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $92.04M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $78.77M 10-K · filed 2020-03-06 |
| 2018-09-30 | $75.02M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $91.75M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $67.75M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $75.38M 10-K · filed 2019-03-06 |
| 2017-09-30 | $59.45M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $63.64M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $71.21M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $74.60M 10-K · filed 2018-03-14 |
| 2016-09-30 | $160.36M 10-Q · filed 2016-11-07 |
| 2015-12-31 | $107.00M 10-K · filed 2017-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |